Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2012
08/29/2012CN101812103B 6-methy salicylic acid synthetase transformed by genetic engineering and combinatorial biosynthesis of spirocyclic acetoacetic acid lactone antiboitic
08/29/2012CN101780172B Bacteriostatic washing liquor with high bacteriostatic action and method for preparing same
08/29/2012CN101732704B Method for preparing inactivated bivalent vaccine against rabbit hemorrhagic disease and pasteurella multocida disease
08/29/2012CN101712686B Method for separating and purifying tacrolimus in fermentation liquor
08/29/2012CN101687887B Tricyclic nitrogen containing compounds as antibacterial agents
08/29/2012CN101659695B O-type aftosa synthetic peptide vaccine
08/29/2012CN101653566B Chinese medicinal compound preparation for treating parotitis
08/29/2012CN101647854B Method for separating total alkaloid from sophora flavescens ait by using ion exchange resin
08/29/2012CN101602656B Synthesis process for hinokitol
08/29/2012CN101583617B 4-(2-oxo-oxazolidin-3yl)-phenoxymethyle derivativeas as antibacterials
08/29/2012CN101574391B Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside
08/29/2012CN101429232B Hcv protease inhibitors
08/29/2012CN101336938B Use of probiotics in preparing composition for treating and preventing hand-foot-mouth disease
08/29/2012CN101331229B Immunostimulatory oligoribonucleotides
08/29/2012CN101264305B Medicaments for treating no fever type common cold
08/29/2012CN101040837B Itracomazole cream and the method for preparing the same
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252916 Expression vectors encoding epitopes of target-associated antigens and methods for their design
08/28/2012US8252909 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases
08/28/2012US8252902 Complexing antigen, antibodies; immunoassay
08/28/2012US8252893 CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252782 Monocarbams
08/28/2012CA2606185C Mono-lysine salts of azole compounds
08/28/2012CA2508171C Nicotinamide-based kinase inhibitors
08/28/2012CA2415718C 7-substituted tetracycline compounds
08/28/2012CA2412531C Antimicrobial peptides and methods of use thereof
08/28/2012CA2399172C Cold-adapted equine influenza viruses
08/28/2012CA2395632C A bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
08/23/2012WO2012112489A2 Compositions and methods for the therapy and diagnosis of influenza
08/23/2012WO2012112438A2 Anti-microbial agents and compositions and methods of production and use thereof
08/23/2012WO2012112345A1 Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
08/23/2012WO2012112079A1 IMPROVING CELLULAR IMMUNOTHERAPEUTIC VACCINES EFFICACY WITH GENE SUPPRESSION IN DENDRITIC CELLS AND T-LYMPHOCYTES USING SiRNA
08/23/2012WO2012111920A2 Pharmaceutical composition containing fenofibrate for prevention of sepsis
08/23/2012WO2012110932A1 Antiviral composition
08/23/2012WO2012110672A1 Pharmaceutical composition of acyclovir prodrugs for topical use
08/23/2012WO2012110636A2 Carrier peptides for cell delivery
08/23/2012WO2012110631A1 Pharmaceutical formulation for topical administration comprising b220
08/23/2012WO2012110463A1 Active substance for treating inflammatory disease conditions in the oral cavity
08/23/2012WO2012110249A1 Haprolid and derivatives thereof as inhibitors of hcv
08/23/2012WO2012109798A1 Hbv treatment
08/23/2012WO2012109752A1 Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria
08/23/2012WO2012090218A4 Synergistic effects of the combination of the specific compounds with paracetamol and their effects on various diseases
08/23/2012WO2012087037A3 Novel bacteriophage and antibacterial composition comprising the same
08/23/2012WO2012078121A3 Solid oral dosage form comprising cefdinir
08/23/2012WO2012053827A3 Composition containing peptide ligand bonding with cxcr2 for treating infective and inflammatory diseases
08/23/2012WO2012036520A3 Novel antibiotically active compound and an antibiotic composition comprising the compound
08/23/2012WO2011095768A8 Lantibiotic salts
08/23/2012US20120214967 Cross-linked glycopeptide-cephalosporin antibiotics
08/23/2012US20120214869 Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
08/23/2012US20120214866 Treatment with cytokines
08/23/2012US20120214847 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
08/23/2012US20120214846 Hexahydrocyclopentyl[f]indazole pyridyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators
08/23/2012US20120214834 Immune enhancement composition and kit and use thereof
08/23/2012US20120214833 Solid dispersion of rifaximin
08/23/2012US20120214814 Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at c-17
08/23/2012US20120214804 Pharmaceutical composition comprising indole compound
08/23/2012US20120214783 Viral polymerase inhibitors
08/23/2012US20120214781 Antibacterial Food Composition
08/23/2012US20120214775 Pharmaceutical Salts of 3-O-(3',3'-Dimethylsuccinyl) Betulinic Acid
08/23/2012US20120214759 Treatment of klebsiella pneumoniae infections with antibacterial aminoglycoside compounds
08/23/2012US20120214741 Vdac1 compositions and methods of use thereof for regulating apoptosis
08/23/2012US20120214731 Compound ws 727713
08/23/2012US20120214729 Composition for preventing or treating inflammation
08/23/2012US20120214206 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
08/23/2012US20120213872 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213870 Composition and method for treating liver disease
08/23/2012US20120213851 Solid pharmaceutical compositions containing an integrase inhibitor
08/23/2012US20120213850 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/23/2012US20120213848 Treatment of Infection Using Single Chain Antibody Gene Therapy
08/23/2012US20120213842 Methods of making and using compositions comprising flavonoids
08/23/2012US20120213840 Ocular strips
08/23/2012US20120213835 Compositions Comprising Peroxy alpha-Ketocarboxylic Acid and Methods For Producing and Using the Same
08/23/2012US20120213832 Removable dental curable composition
08/23/2012US20120213829 Dry powder aerosols of nanoparticulate drugs
08/23/2012US20120213828 Adenovirus vaccine vector and methods of use
08/23/2012US20120213825 Antibiotic product, use and formulation thereof
08/23/2012US20120213824 Use of pufas for treating skin inflammation
08/23/2012US20120213823 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213821 Novel method for isolating endotoxins
08/23/2012US20120213820 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
08/23/2012US20120213819 Hemagglutinin polypeptides, and reagents and methods relating thereto
08/23/2012US20120213818 Combination therapy for immunostimulation
08/23/2012US20120213817 Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
08/23/2012US20120213816 Mycoplasma hyopneumoniae bacterin vaccine
08/23/2012US20120213815 Vaccines and immunotherapeutics using codon-optimized il-15 and methods for using the same
08/23/2012US20120213813 Alphavirus replicon particles as immunological adjuvants
08/23/2012US20120213811 Chimeric hiv fusion proteins as vaccines
08/23/2012US20120213810 Novel european prrsv strain
08/23/2012US20120213802 PAR-1 Antagonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
08/23/2012US20120213791 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
08/23/2012US20120213790 Methods of treatment using il-16 antagonist peptides
08/23/2012US20120213780 Efficient mucosal vaccination mediated by the neonatal Fc receptor
08/23/2012US20120213777 Vascular endothelial growth factor 2
08/23/2012US20120213770 Compostions and methods for identifying response targets and treating flavivirus infection responses
08/23/2012US20120213767 Extended Soluble PH20 Polypeptides and uses thereof
08/23/2012US20120213764 Novel method for the production of a antimicrobial peptide
08/23/2012US20120213755 Semi-synthetic platelet gel and method for the preparation thereof
08/23/2012US20120213739 Method to grow lawsonia intracellularis bacteria in persistently infected mccoy cells
08/23/2012US20120213735 Therapeutic furopyrimidines and thienopyrimidines
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 1798